Evangelos Eleftherakis-Papaiakovou

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

Meletios Α. Dimopoulos, Efstathios Kastritis, Christina Bamia et al. · Annals of Oncology · 2008 · 437 citations · Full text

Medicine, Oncology, Bone Metabolism +9

Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

Efstathios Kastritis, Evangelos Terpos, Lia A. Moulopoulos et al. · Leukemia · 2012 · 159 citations

Medicine, Hematology, Pathology +17

The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis

Evangelos Terpos, Efstathios Kastritis, D Heath et al. · Leukemia · 2008 · 115 citations

Medicine, Hematology, Pharmacology +17

Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival

Stavroula Α. Paschou, Evangelos Eleftherakis-Papaiakovou, Katerina Stefanaki et al. · Frontiers in Oncology · 2022 · 22 citations · Full text

Medicine, Immunology, Oncology +14

Expression of CCL3 by Neoplastic Cells in Patients with Waldenström's Macroglobulinemia: An Immunohistochemical Study in Bone Marrow Biopsies of 67 Patients

Evangelos Terpos, Anna Tasidou, Evangelos Eleftherakis-Papaiakovou et al. · Clinical Lymphoma Myeloma & Leukemia · 2011 · 10 citations

Medicine, Oncology, Pathology +15